December 16th 2020, 9:26pm
There are several signs characteristic of obstructive sleep apnea (OSA) in children and adolescents, but a sleep study interpreted according to pediatric standards is the only way to properly diagnose conditions such as sleep apnea, restless leg syndrome, or primary snoring in these populations.
December 12th 2020, 2:00pm
Among patients with obstructive sleep apnea (OSA), the presence of anxiety was shown to have an inverse relationship with the severity of OSA, whereas symptoms of depression did not exhibit a similar relationship.
December 9th 2020, 2:00pm
New devices can help to manage sleep apneas, but underlying conditions must be treated, too, noted Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, medical director, Sleep-Wake Center, University of Utah.
December 4th 2020, 7:45pm
Among patients with obstructive sleep apnea (OSA), reduced dominant hand grip strength was found to correlate with lower oxygen nadir and increased apnea duration, with fat mass also consistently associated with worsening OSA indices.
November 30th 2020, 6:31pm
Incidence and prevalence rates of narcolepsy were assessed in a meta-review of 30 countries, with a trend of underreporting found in ethnic/race and gender minorities, childhood narcolepsy type 2, and among patients with comorbid conditions.
November 27th 2020, 3:00pm
Intermittent hypoxia sensitizes control centers in the brain, noted Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, and medical director, Sleep-Wake Center, University of Utah.
November 25th 2020, 3:00pm
Teens with migraines attending high schools starting before 8:30 am were found to experience an average 7.7 headache days per month, nearly 3 more headache days than those with later school start times, according to study findings published today.
November 21st 2020, 3:30pm
More than 1 in 4 patients with COVID-19 admitted to the hospital during the first wave of the pandemic in Finland were found to have obstructive sleep apnea, signaling a potential at-risk population.
November 18th 2020, 7:00pm
Results from a phase 3 study of Xywav in adult patients with idiopathic hypersomnia exhibited its potential to address this unmet medical need.
November 13th 2020, 1:00pm
Age, sex, and body mass index typically drive the development of obstructive sleep apnea, noted Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, medical director, Sleep-Wake Center, University of Utah.
